This is a side-by-side of what is documented, not a ranking. Different compounds are studied for different things, in different people, at different amounts. A row that looks stronger for one compound does not make it the better choice for anyone.
| 5-Amino-1MQ | Adipotide | |
|---|---|---|
| Highest evidence tier on the page | E4 Preclinical only Animal or in vitro work. Not demonstrated in humans. | E3 Early human evidence Small, open-label, uncontrolled, case series, or a registered trial with no published results. |
| Regulatory status | Not approved for human use | Not stated |
| Research area | Metabolic and incretin | Metabolic and incretin |
| Regulator-approved dose on file | No approved dose | No approved dose |
| Molecular formula | C10H11N2+ (free cation); C10H11ClN2 (chloride salt) | C111H206N36O28S2 (per PubChem) |
| Molar mass | 159.21 g/mol, calculated for the free cation; 194.66 g/mol, calculated for the chloride salt | Not independently re-derived for this entry from an authoritative source; PubChem lists the compound under the formula above without an easily accessible listed molecular weight in the pages reviewed. Regard any specific mass figure seen elsewhere online as unverified until confirmed against PubChem directly. |
| CAS number | 685079-15-6 (free cation); no independently confirmed CAS number exists for the chloride salt | 859216-15-2 |
| Registered trials on this site | None linked yet | 1 in the tracker |
| What is not known | Everything about this compound in a human being. No interventional trial, observational study or published case report of 5-Amino-1MQ administered to a person exists, so whether it has any effect, at any dose, with any safety profile, in a human is entirely unanswered. Any human... | Whether Adipotide is safe or effective in a general, non-cancer, human obesity population; no such trial has ever been conducted. The specific human doses used in the one Phase I trial that was conducted (NCT01262664), and its results, since the trial was terminated with only... |
| Furthest registered phase | Not stated | Phase 1 |
| Trials currently active | Not stated | 0 |
| Trial sponsors | Not stated | M.D. Anderson Cancer Center |
Full pages: 5-Amino-1MQ and Adipotide. See also the clinical trial tracker and how we grade evidence.
Educational reference, not medical advice. Trial data from ClinicalTrials.gov. Everything else is drawn from the compound pages on this site, each of which cites its sources.
